<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dore E</submitter><funding>Natural Sciences and Engineering Research Council of Canada</funding><pagination>e152638</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8855825</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(2)</volume><pubmed_abstract>Secreted phospholipase A2-IIA (sPLA2-IIA) hydrolyzes phospholipids to liberate lysophospholipids and fatty acids. Given its poor activity toward eukaryotic cell membranes, its role in the generation of proinflammatory lipid mediators is unclear. Conversely, sPLA2-IIA efficiently hydrolyzes bacterial membranes. Here, we show that sPLA2-IIA affects the immune system by acting on the intestinal microbial flora. Using mice overexpressing transgene-driven human sPLA2-IIA, we found that the intestinal microbiota was critical for both induction of an immune phenotype and promotion of inflammatory arthritis. The expression of sPLA2-IIA led to alterations of the intestinal microbiota composition, but housing in a more stringent pathogen-free facility revealed that its expression could affect the im</pubmed_abstract><journal>JCI insight</journal><pubmed_title>The interaction of secreted phospholipase A2-IIA with the microbiota alters its lipidome and promotes inflammation.</pubmed_title><pmcid>PMC8855825</pmcid><funding_grant_id>RGPIN-2016-05830</funding_grant_id><pubmed_authors>Rangachari M</pubmed_authors><pubmed_authors>Davidovic L</pubmed_authors><pubmed_authors>Cloutier N</pubmed_authors><pubmed_authors>Boilard E</pubmed_authors><pubmed_authors>Morozumi S</pubmed_authors><pubmed_authors>Allaeys I</pubmed_authors><pubmed_authors>Duchez AC</pubmed_authors><pubmed_authors>Payre C</pubmed_authors><pubmed_authors>Arita M</pubmed_authors><pubmed_authors>Martin C</pubmed_authors><pubmed_authors>Joly-Beauparlant C</pubmed_authors><pubmed_authors>Flamand N</pubmed_authors><pubmed_authors>Droit A</pubmed_authors><pubmed_authors>Bodein A</pubmed_authors><pubmed_authors>Petit-Paitel A</pubmed_authors><pubmed_authors>Levesque T</pubmed_authors><pubmed_authors>Lambeau G</pubmed_authors><pubmed_authors>Gelb MH</pubmed_authors><pubmed_authors>Murakami M</pubmed_authors><pubmed_authors>Dore E</pubmed_authors><pubmed_authors>Mathieu A</pubmed_authors><pubmed_authors>Leclercq M</pubmed_authors></additional><is_claimable>false</is_claimable><name>The interaction of secreted phospholipase A2-IIA with the microbiota alters its lipidome and promotes inflammation.</name><description>Secreted phospholipase A2-IIA (sPLA2-IIA) hydrolyzes phospholipids to liberate lysophospholipids and fatty acids. Given its poor activity toward eukaryotic cell membranes, its role in the generation of proinflammatory lipid mediators is unclear. Conversely, sPLA2-IIA efficiently hydrolyzes bacterial membranes. Here, we show that sPLA2-IIA affects the immune system by acting on the intestinal microbial flora. Using mice overexpressing transgene-driven human sPLA2-IIA, we found that the intestinal microbiota was critical for both induction of an immune phenotype and promotion of inflammatory arthritis. The expression of sPLA2-IIA led to alterations of the intestinal microbiota composition, but housing in a more stringent pathogen-free facility revealed that its expression could affect the im</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2026-05-30T23:54:54.471Z</modification><creation>2025-04-04T23:29:06.051Z</creation></dates><accession>S-EPMC8855825</accession><cross_references><pubmed>35076027</pubmed><doi>10.1172/jci.insight.152638</doi></cross_references></HashMap>